Skip to main content

HEADINVEST, LLC

Position in NVO — Novo Nordisk A S

CIK 1372130 Portland, ME

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,247,004
+$826,755 QoQ
Shares Held
88,590
-4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#239
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. NVO ranks #1 (27.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
88,590 $4,247,004

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,247,004 88,590
2026-03-31 $3,420,249 93,068
2025-12-31 $5,380,458 105,748
2025-09-30 $6,273,921 113,064
2025-06-30 $8,074,580 116,989
2025-03-31 $7,914,493 113,976
2024-12-31 $9,997,846 116,227
2024-09-30 $14,258,275 119,747
2024-06-30 $17,788,544 124,622
2024-03-31 $16,529,188 128,732
2023-12-31 $14,132,407 136,611
2023-09-30 $12,642,296 139,018
2023-06-30 $11,347,357 70,119
2023-03-31 $12,144,132 76,311
2022-12-31 $11,312,799 83,588
2022-09-30 $8,599,164 86,311
2022-06-30 $9,779,765 87,766
2022-03-31 $9,897,664 89,128
2021-12-31 $10,169,040 90,795
2021-09-30 $9,010,250 93,847
2021-06-30 $7,933,521 94,706
2021-03-31 $6,408,203 95,049
2020-12-31 $6,690,861 95,789
2020-09-30 $6,420,122 92,469
2020-06-30 $6,132,463 93,654
2020-03-31 $5,699,194 94,671